PFE expects $15B*_2021_COVID-19_sales—raises_2021_EPS†_guidance—>3.10-3.20 (from prior range of $3.00-3.10)… PR: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-reports-fourth-quarter-and-full-year-2020-results CC slides: https://s21.q4cdn.com/317678438/files/doc_financials/2020/q4/Q4-2020-Earnings-Charts-FINAL.pdf *PFE and BNTX split profits on the COVID-19 vaccine. †Non-GAAP.